首页    期刊浏览 2024年07月07日 星期日
登录注册

文章基本信息

  • 标题:Effects of Two Different Dietary Patterns on Inflammatory Markers, Advanced Glycation End Products and Lipids in Subjects without Type 2 Diabetes: A Randomised Crossover Study
  • 本地全文:下载
  • 作者:Yoona Kim ; Jennifer B. Keogh ; Peter M. Clifton
  • 期刊名称:Nutrients
  • 电子版ISSN:2072-6643
  • 出版年度:2017
  • 卷号:9
  • 期号:4
  • 页码:336
  • DOI:10.3390/nu9040336
  • 语种:English
  • 出版社:MDPI Publishing
  • 摘要:Epidemiological studies suggest that consumption of red and processed meat and refined grains are associated with type 2 diabetes and metabolic syndrome and increased inflammatory and fibrinolytic markers. We hypothesised that a diet high in red and processed meat and refined grains (HMD) would increase inflammatory markers and advanced glycation end products (AGEs) compared with a diet high in dairy, whole grains, nuts and legumes (HWD). We performed a randomised crossover study of two four-week interventions in 51 participants without type 2 diabetes (15 men and 36 women aged 35.1 ± 15.6 years; body mass index: 27.7 ± 6.9 kg/m2). No baseline measurements were performed. Plasma fluorescent AGEs, carboxymethyllysine, glucose, insulin, lipids, hs-CRP, interleukin 6 (IL-6) and plasminogen activator inhibitor-1 (PAI-1) were analysed after four weeks on each diet. IL-6, hs-CRP, AGEs and carboxymethyllysine were not different between diets but PAI-1 was higher after the HMD than after HWD ((median and interquartile range) 158, 81 vs. 121, 53 ng/mL p < 0.001). PAI-1 on the HWD diet was inversely correlated with whole grains intake (p = 0.007). PAI-1 was inversely correlated with insulin sensitivity index (r = −0.45; p = 0.001) and positively correlated with serum total cholesterol (r = 0.35; p = 0.012) and serum triglyceride (r = 0.32; p = 0.021) on HMD. This trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12614000519651).
  • 关键词:dietary pattern; plasminogen activator inhibitor type 1; advanced glycation products; insulin sensitivity dietary pattern ; plasminogen activator inhibitor type 1 ; advanced glycation products ; insulin sensitivity
国家哲学社会科学文献中心版权所有